Document Detail


Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: precommitment memory associated with altered nuclear structure.
MedLine Citation:
PMID:  6583206     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The cell differentiation of HL-60 human leukemic promyelocytes along the myeloid pathway due to various continuous and distributed exposures to retinoic acid was studied. HL-60 myeloid differentiation was a continuously driven process; significant terminal cell differentiation occurred only after a minimum exposure to inducer of two division cycles. Cells so committed to differentiation retained a heritable, finite memory of differentiation commitment over a further division cycle. Prior to becoming committed, cells acquired precommitment memory of exposure to inducer. Precommitment memory abbreviated the subsequent exposure to inducer needed for commitment to differentiation. Precommitment memory was semistable. It was heritable, but was lost after four division cycles. The acquisition and loss of precommitment memory correlated with alterations in nuclear architecture detected by narrow angle light scatter using flow cytometry. The altered nuclear architecture first occurred before any overt cell differentiation or growth arrest. It was thus an early event in the induced program of terminal cell differentiation. Alterations in relative abundances of cytoplasmic proteins also occurred prior to overt cell differentiation or growth arrest. One of these was a 17 kdalton, anionic, probably Ca2+ binding, protein. Retinoic acid thus induced early cellular changes, including cytoplasmic and nuclear alterations, within one cell cycle when cell differentiation was not yet apparent.
Authors:
A Yen; S L Reece; K L Albright
Related Documents :
21319296 - Biomaterials coated by dental pulp cells as substrate for neural stem cell differentiat...
20888316 - Highly efficient reprogramming to pluripotency and directed differentiation of human ce...
17366826 - Screening for developmental neurotoxicity using pc12 cells: comparisons of organophosph...
289436 - Inhibition by dexamethasone of commitment to erythroid differentiation in murine erythr...
15141316 - Immunophenotype and possible origin of nevi with phenotypical heterogeneity.
1098046 - Changing patterns of actin localization during cell division.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of cellular physiology     Volume:  118     ISSN:  0021-9541     ISO Abbreviation:  J. Cell. Physiol.     Publication Date:  1984 Mar 
Date Detail:
Created Date:  1984-04-06     Completed Date:  1984-04-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0050222     Medline TA:  J Cell Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  277-86     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Line
Cell Nucleus / ultrastructure
Cell Transformation, Neoplastic / drug effects*
Cells, Cultured
Humans
Leukemia, Myeloid, Acute / pathology*
Tretinoin / administration & dosage*,  pharmacology
Grant Support
ID/Acronym/Agency:
CA 31591/CA/NCI NIH HHS; CA 33505/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
302-79-4/Tretinoin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
Next Document:  Determination of a new antibacterial agent (AT-2266) and its metabolites in plasma and urine by high...